Gut microbiota mediates the protective effects of dietary β‐hydroxy‐β‐methylbutyrate (HMB) against obesity induced by high‐fat diets

Abstract

Obesity increases the risk of developing insulin resistance and diabetes and is a major public health concern. Our previous study shows that dietary β‐hydroxy‐β‐methylbutyrate (HMB) improves lipid metabolism in a pig model. However, it remains unclear whether HMB blocks obesity through gut microbiota. In this study, we found that HMB reduced body weight, alleviated the whitening of brown adipose tissue, and improved insulin resistance in mice fed a high‐fat diet (HFD). High‐throughput pyrosequencing of the 16S rRNA demonstrated that HMB administration significantly reversed the gut microbiota dysbiosis in HFD‐fed mice, including the diversity of gut microbiota and relative abundances of Bacteroidetes and Firmicutes. Moreover, microbiota transplantation from HMB‐treated mice attenuated HFD‐induced lipid metabolic disorders. Furthermore, HFD‐fed mice showed lower short‐chain fatty acids, whereas administration of HMB increased the propionic acid production. Correlation analysis identified a significant correlation between propionic acid production and the relative Bacteroidetes abundance. Sodium propionate treatment also attenuated HFD‐induced lipid metabolic disorders. Collectively, our results indicated that HMB might be used as a probiotic agent to reverse HFD‐induced obesity, and the potential mechanism was associated with reprogramming gut microbiota and metabolism, especially Bacteroidetes‐mediated propionic acid production. In future studies, more efforts should be made to confirm and expand the beneficial effects of HMB to human models.—Duan, Y., Zhong, Y., Xiao, H., Zheng, C., Song, B., Wang, W., Guo, Q., Li, Y., Han, H., Gao, J., Xu, K., Li, T., Yin, Y., Li, F., Yin, J., Kong, X. Gut microbiota mediates the protective effects of dietary β‐hydroxy‐β‐methylbutyrate (HMB) against obesity induced by high‐fat diets. FASEB J. 33, 10019–10033 (2019). http://www.fasebj.org

Preventive Effects of Kaempferol on High‐Fat Diet‐Induced Obesity Complications in C57BL/6 Mice

“…The key to understanding obesity may be related to changes in the gut microbiota and its function in response to diet [26]. Several studies confirm that in both human and rat models, the gut microbiota in obesity exhibits greater relative abundance of Firmicutes and decreased levels of Bacteroidetes [27][28][29]. In line with these findings, this study found relative changes in the gut microbiota of HFD mice, showing that kaempferol supplementation led to lower levels of Firmicutes and higher levels of Bacteroidetes.…”

Phellinus linteus polysaccharide extract improves insulin resistance by regulating gut microbiota composition

“…38,39 Analysis of fecal samples of type 2 diabetes patients revealed reductions of gut microbiota diversity and abundance of butyrate-producing bacteria (eg, Roseburia, Faecalibacterium prausnitzii), and increased levels of certain conditionally pathogenic bacteria such as Escherichia coli. 38,39 Analysis of fecal samples of type 2 diabetes patients revealed reductions of gut microbiota diversity and abundance of butyrate-producing bacteria (eg, Roseburia, Faecalibacterium prausnitzii), and increased levels of certain conditionally pathogenic bacteria such as Escherichia coli.…”

Circadian rhythms and obesity: Timekeeping governs lipid metabolism

“…The gut microbiota have been identified as an environmental factor that markedly affects digestive capacity, nutritional absorption, energy balance, and body fat accumulation in mammals. [81][82][83][84] Germ-free animal and fecal microbial transplantation provide direct insights into the function of gut microbiota in host lipid metabolism and obesity development. Germ-free mice fail to gain additional weight and remain lean compared to conventionally raised counterparts.…”